Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is now a common cause of cancer death, with no obvious change in patient survival over the past few years. Although the traditional therapeutic modalities for HCC patients mainly involved in surgery, chemotherapy, and radiotherapy, which have achieved admirable achieve...

Full description

Bibliographic Details
Main Authors: Shijing Yu, Ruirui Zhao, Bingchen Zhang, Chunmei Lai, Linyan Li, Jiangwen Shen, Xiarong Tan, Jingwei Shao
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Hepatocellular carcinoma
CRISPR/Cas9
Screen gene
Delivery strategy
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087623000557

Similar Items

Similar Items